The identification of tau as the major component of fibrillar inclusions deposited in the brains of patients with neurodegenerative diseases, including Alzheimer’s disease, chronic traumatic encephalopathy, progressive supranuclear palsy, corticobasal degeneration, and frontotemporal lobar degeneration with tau pathology, has attracted significant attention. The gene discussed is MAPT; the disease is Alzheimer disease.